BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Resolvyx Pharmaceuticals, Inc. 

6A Preston Court

Bedford  Massachusetts  01730  U.S.A.
Phone: 781-541-5045 Fax: 781-541-5046


SEARCH JOBS




Industry
Biotechnology






 Company News
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Enter Final Agreement in Ophthalmology 1/10/2011 6:23:25 AM    More...
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Ink Dry Eye Deal 10/26/2010 7:58:47 AM    More...
Resolvyx Pharmaceuticals, Inc. Presents Data Demonstrating Potential for Resolvin Therapeutics to Treat Corneal and Retinal Eye Diseases at ARVO 2010 Meeting 5/6/2010 11:17:18 AM    More...
Resolvyx Pharmaceuticals, Inc. Granted U.S. Patent for the First Resolvin Therapeutic to Enter Human Trials 9/18/2009 9:53:04 AM    More...
Resolvyx Pharmaceuticals, Inc. Announces Positive Data from Phase 2 Clinical Trial of the Resolvin RX-10045 in Patients with Dry Eye Syndrome 8/24/2009 6:27:58 AM    More...
Resolvyx Pharmaceuticals, Inc. Initiates Phase I Clinical Trial of Novel Resolvin, RX-10001, for Asthma and Inflammatory Diseases 6/23/2009 9:31:05 AM    More...
Resolvyx Pharmaceuticals, Inc. Presents Data Demonstrating Potential for Resolvin Therapeutics to Treat Corneal and Retinal Eye Diseases at Association for Research in Vision & Ophthalmology 2009 Meeting 5/6/2009 9:05:22 AM    More...
Resolvyx Pharmaceuticals, Inc. to Present Data on Novel Resolvin Drug Candidates for Eye Disease at ARVO Annual Meeting 4/27/2009 10:51:28 AM    More...
Resolvyx Pharmaceuticals, Inc. Appoints Industry Leader Philip Vickers as Chief Scientific Officer 4/15/2009 9:22:57 AM    More...
Resolvyx Pharmaceuticals, Inc. Announces Initiation of Phase I/II Clinical trial of Novel Resolvin Therapeutic RX-10045 in Patients with Dry Eye 12/18/2008 10:58:16 AM    More...
12